A comprehensive analysis section that covers unveiling insights about Intra-Cellular Therapies, Inc.'s gradings, price targets and earnings estimates.
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2015 | -1.0700 | -3.134 | 0.58 | 0.14 | -30 | -101 | -30 | -101 | -30 | -102 | 10 | 31 |
2016 | -2.9100 | -2.818 | 0.09 | 0.23 | -104 | -270 | -105 | 0.20 | -105 | 0.20 | 18 | 50 |
2017 | -2.6900 | -2.087 | 0.33 | 0.25 | -116 | -200 | -115 | 0.21 | -118 | 0.21 | 24 | 53 |
2018 | -2.1200 | -2.998 | 0.25 | 0.05 | -97 | -170 | -98 | -177 | -102 | -178 | 23 | 10 |
2020 | -2.6800 | -3.331 | 0.06 | 22 | -147 | -251 | -154 | -251 | -154 | -256 | 64 | 4,817 |
2021 | -3.2300 | -3.454 | 22 | 83 | -227 | -331 | -231 | -72 | -231 | -72 | 186 | 18,049 |
2022 | -3.5000 | -2.873 | 81 | 249 | -284 | -327 | -285 | -326 | -285 | -330 | 272 | 54,135 |
2023 | -2.7200 | -1.616 | 249 | 468 | -256 | -139 | -263 | -374 | -263 | -378 | 358 | 376 |
2024 | -1.4600 | -0.613 | 462 | 673 | -139 | -58 | -158 | -585 | -159 | -585 | 409 | 146,306 |
2025 | - | 0.485 | - | 938 | - | 50 | - | -814 | - | -815 | - | 203,631 |
2026 | - | 3.625 | - | 1,407 | - | 2.F10X | - | 2.F101 | - | 2.F1011 | - | 2.F1011 |
2027 | - | 7.808 | - | 1,999 | - | 1.F11X | - | 1.F111 | - | 1.F1111 | - | 1.F1111 |
2028 | - | 11.520 | - | 2,618 | - | 0.F12X | - | 0.F121 | - | 0.F1211 | - | 0.F1211 |